Abbott Laboratories Debt Issuance/Retirement Net - Total 2010-2025 | ABT

Abbott Laboratories annual/quarterly debt issuance/retirement net - total history and growth rate from 2010 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  • Abbott Laboratories debt issuance/retirement net - total for the quarter ending March 31, 2025 was $-1.036B, a 715.75% increase year-over-year.
  • Abbott Laboratories debt issuance/retirement net - total for the twelve months ending March 31, 2025 was $-1.464B, a 64.88% decline year-over-year.
  • Abbott Laboratories annual debt issuance/retirement net - total for 2024 was $-0.537B, a 78.3% decline from 2023.
  • Abbott Laboratories annual debt issuance/retirement net - total for 2023 was $-2.475B, a 254.08% increase from 2022.
  • Abbott Laboratories annual debt issuance/retirement net - total for 2022 was $-0.699B, a 181.85% increase from 2021.
Abbott Laboratories Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2024 $-537
2023 $-2,475
2022 $-699
2021 $-248
2020 $-50
2019 $-1,599
2018 $-8,450
2017 $-2,942
2016 $13,155
2015 $1,147
2014 $766
2013 $1,792
2012 $4,413
2011 $-3,977
2010 $2,122
2009 $3,734
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $228.771B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $153.093B 38.33
Stryker (SYK) United States $149.084B 31.17
EssilorLuxottica (ESLOY) France $130.144B 0.00
Medtronic (MDT) Ireland $114.429B 16.22
Lonza Group Ag (LZAGY) Switzerland $49.231B 0.00
Haleon (HLN) United Kingdom $43.710B 24.95
ResMed (RMD) United States $36.952B 27.75
GE HealthCare Technologies (GEHC) United States $34.062B 16.17
Agilent Technologies (A) United States $32.082B 20.92
Terumo (TRUMY) Japan $24.207B 31.44
Koninklijke Philips (PHG) Netherlands $23.216B 16.29
Insulet (PODD) United States $20.408B 80.11
Zimmer Biomet Holdings (ZBH) United States $18.604B 11.95
Baxter (BAX) United States $14.497B 10.82
Smith & Nephew SNATS (SNN) United Kingdom $12.846B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.731B 23.42
Lantheus Holdings (LNTH) United States $5.622B 14.18
Perrigo (PRGO) Ireland $3.719B 9.43
Prestige Consumer Healthcare (PBH) United States $3.714B 16.59
Haemonetics (HAE) United States $3.585B 16.33
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.358B 27.90
ICU Medical (ICUI) United States $3.113B 22.96
QuidelOrtho (QDEL) United States $1.890B 13.00
LeMaitre Vascular (LMAT) United States $1.858B 41.53
AtriCure (ATRC) United States $1.512B 0.00
Acuren (TIC) United States $1.407B 0.00
Green Thumb Industries (GTBIF) United States $1.245B 28.00
Phibro Animal Health (PAHC) United States $1.239B 15.83
AdaptHealth (AHCO) United States $1.205B 12.23
Neogen (NEOG) United States $1.079B 13.81
BioLife Solutions (BLFS) United States $0.994B 0.00
InMode (INMD) Israel $0.901B 9.08
Kestra Medical Technologies (KMTS) United States $0.836B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.660B 0.00
Owens & Minor (OMI) United States $0.600B 4.98
Evolus (EOLS) United States $0.598B 0.00
Tilray Brands (TLRY) Canada $0.597B 0.00
CeriBell (CBLL) United States $0.569B 0.00
Valneva SE (VALN) France $0.549B 0.00
Surmodics (SRDX) United States $0.448B 0.00
SNDL (SNDL) Canada $0.397B 0.00
Capricor Therapeutics (CAPR) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.318B 11.71
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.285B 0.00
Quanterix (QTRX) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cresco Labs (CRLBF) United States $0.258B 0.00
Cerus (CERS) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.246B 11.19
Sanara MedTech (SMTI) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.233B 0.00
Brainsway (BWAY) Israel $0.231B 61.00
Biote (BTMD) United States $0.216B 6.06
Omeros (OMER) United States $0.212B 0.00
Canopy Growth (CGC) Canada $0.200B 0.00
Verano Holdings (VRNOF) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Vireo Growth (VREOF) United States $0.155B 0.00
Exagen (XGN) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.124B 15.25
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.099B 12.80
MacroGenics (MGNX) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Veru (VERU) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.080B 0.00
Apyx Medical (APYX) United States $0.077B 0.00
Zynex (ZYXI) United States $0.069B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United-Guardian (UG) United States $0.042B 14.41
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.024B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00